de web@aimee.ro | nov. 29, 2019 | Fără categorie
Generic medicine producers that do not benefit from the introduction of new molecules on the list, would be severely affected by an unfair tax burden, with serious consequences for patient access to affordable treatment. The strict criteria introduced by the Ministry... de web@aimee.ro | nov. 29, 2019 | Fără categorie
The European Generic medicines Association (EGA) and its European Biosimilars Group (EBG) welcome the publication of a consensus information document on biosimilar medicines on the European Commission website. It is the result of extensive collaboration of a... de web@aimee.ro | nov. 29, 2019 | Fără categorie
The Association of Generic Medicine Producers in Romania (APMGR), association representing the interests of the main investors present on the Romanian market, asks the authorities to recalculate the cuantum of the clawback tax for the fourth quarter of 2012, in order... de web@aimee.ro | nov. 29, 2019 | Fără categorie
THE CODE OF ETHICAL CONDUCT CONTAINS A BINDING SET OF PRINCIPLES, TRANSPARENCY RULES AND SANCTIONS APPLICABLE TO ALL MEMBER COMPANIES OF APMGR THE UNDERTAKING, COMPLIANCE AND IMPLEMENTATION OF THIS CODE OF ETHICS WILL BE MANDATORY REQUIREMENTS FOR ANY COMPANY THAT... de web@aimee.ro | nov. 29, 2019 | Fără categorie
Generic medicine producers welcome the decision of the Constitutional Court to declare unconstitutional the Government Emergency Ordinance 77/2011 regarding the clawback tax Furthermore, third party markups need to be removed from the tax base and the tax clawback,...